Metanephrines are O-methylated metabolites of catecholamines. We report the use of liquid chromatography with electrochemical detection to determine plasma concentrations of normetanephrine (NMN) and metanephrine (MN). Plasma NMN and MN in 32 normal volunteers and inpatients were compared with concentrations in 23 patients with pheochromocytoma. Metanephrines were adsorbed from plasma onto a cation-exchange column and eluted with ammoniacal methanol. The dried residue was dissolved in mobile phase and injected onto a reversedphase column. Recoveries of NMN and MN from 1 mL of plasma averaged 50-70%, and resultsvaried linearlywith quantity injected over a range of 0.13-55 pmol. The detection limit was 25 fmol for NMN and 50 fmol for MN. Intra-assay CVs were <5%. In normal volunteers and inpatients, plasma concentrations of NMN ranged between 0.12 and 0. agreed with those determined by the radioenzymatic method (8) . Although the sensitivity of this last chromatographic method was sufficient for measuring total plasma metanephrines (free and conjugated), the amount of free metanephrines in 1 mL of plasma was closeto the detection limit of that assay.
in urine (2) (3) (4) (5) and brain tissue (6, 7) . Because of the low concentrations of NMN and MN in plasma, measurement of metanephrines in this fluid matrix has been more difficult than in urine and tissue. Adequate sensitivity for measurement of plasma NMN has been achieved with a radioenzymatic technique (8), but this method does not measure plasma MN. Three liquid-chromatographic procedures for measurement of plasma metanephrines have been described (9) (10) (11) . Two yielded unrealistically high plasma concentrations of NMN (9, 10) , but estimates with the third, more recent, procedure (11) agreed with those determined by the radioenzymatic method (8) . Although the sensitivity of this last chromatographic method was sufficient for measuring total plasma metanephrines (free and conjugated), the amount of free metanephrines in 1 mL of plasma was closeto the detection limit of that assay.
Here we describe a method utilizing liquid chromatography with electrochemical detection, with adequate sensitivity for reliable measurement of both NMN and MN in 1 mL of plasma. Plasma concentrations measured in normal volunteers and in hospital inpatients were compared with those in patients with pheochromocytoma, a rare tumor that secretes catecholamines into the blood stream.
MaterIals and Methods

Materials
Apparatus.
To extract NMN and MN from plasma, we used an AccuCAT 
Procedures
Extraction.
To activate the solid-phase cation-exchange matrix, we passed through the extraction col- 
Assay validation.
We examined the detector response relative to amounts of injected NMN and MN standards and as functions of oxidizing potential or mobile phase pH. Limits of detection were calculated as the amount of injected NMN or MN that gave a detector response threefold greater than the baseline fluctuation. Intra-assay CVs were determined by measuring plasma NMN and MN in multiple pooled plasma samples that were extracted and assayed over the course of 1 day.
Interassay
CVs were assessed by repeated measurements of plasma NMN and MN in pooled plasma samples on separate days. Intra-and interassay CVs were then determined for aliquots of a pooled plasma sample drawn from healthy subjects at rest (low normal range) and in a pooled sample from subjects after moderate exercise (high normal range).
We examined several compounds for possible interference with plasma NMN and MN determinations, including norepinephrine, epinephrine, isoproterenol, phentolamine, propranolol, indomethacin, yohimbine, desipramine, and acetaminophen. Compounds that were detectable after direct injection were then examined for interference after extraction from plasma.
Statistics.
Differences between recoveries of metanephrines and internal standards were assessed by analysis of variance with post hoc tests carried out by Scheffe'smethod (13) .
Results
Chromatography.
The endogenous metanephrines (NMN, MN, and MHPEA) and the exogenous internal standards (FNMN, HMBA, EHPEA) were separated from each other and were all eluted from the column within 30 mm after injection (Figure 2, upper panel) . After extraction from plasma, NMN and MN were usually the most prominent endogenous compounds detected (Figure 2 , middle and lower panels). Two other unknown compounds were always present on chromatograms of extracted plasma: one compound cochromatographed with the FNMN internal standard, and another eluted immediately after the EHPEA internal standard. The O-methylated metabolite of dopamine, MHPEA, was not detected in plasma samples from normal volunteers or hospital inpatients, but was occasionally detected in samples from patients with pheochromocytoma.
Sensitivity.
Maximum detector responsesto injection of both NMN and MN standards were attained at a reducing potential of -0.43 V at the third electrode. On this basis, and because of the instability of the detector output beyond -0.40 V, we chose a potential of -0.39 V for optimal detection of metanephrines. At this detecting potential, the electrochemical response varied linearly with the amounts of injected NMN or MN from 0.13 to 55 pmol.
The detector response to injection of MN standard was severely compromised when the pH of the mobile phase exceeded 3.5; at pH 4.0, the detector response was reduced by 55% and at pH 4.5 was reduced by 90%. The response for all other standards was unaffected. To optimize detection of MN, we therefore maintained the pH of the mobile phase between 3.2 and 3.4. Within this pH range and at the reducing potential stipulated above, the detection limit of the assay (signal-to-noise ratio of 3:1) was 25 fmol for NMN, 50 fmol for MN, and 120 fmol for MHPEA. (Figure 3) .
Precision.
Intra-assay
CVs were <5% for plasma concentrations of NMN and MN in the normal range (Table 2) . Interassay CVs were greater, but were <11% for plasma NMN and MN concentrations in the highnormal range and <16.5% for concentrations in the low-normal range.
Specificity. Of the substances tested for chromatographic interference, only norepinephrine, epinephrine, isoproterenol, and acetaminophen were detected after direct injection ( Table 3) In patients with pheochromocytoma, the plasma con- 
Discussion
The few reports that describe methods for measuring plasma metanephrines yield inconsistent results. Using a radioenzymatic method, DeQuattro and colleagues (8, 14) reported plasma concentrations of free NMN of 0.33-0.66 nmol/L in normal volunteers, whereas others have reported plasma NMN concentrations of 1.8 to 3.1 nmol/L (9) or >21 nmol/L (10) by liquid-chromatographic procedures. Plasma concentrations of free MN were estimated to be between 1.9 and 2.4 nmoIJL by one method (9) and undetectable by the other (10) . Because the radioenzymatic assay depends on the enzymatic conversion of NMN to tritium-labeled MN, plasma MN could not be measured by this method.
Recently, a liquid-chromatographic method was described for simultaneous measurements of plasma concentrations of NMN and MN (11) . Plasma concentrations of free NMN estimated by this method (-0.44 nmolfL) were similar to those reported by the radioenzymatic method (8, 14) . Plasma concentrations of MN were onethird to one-half those of NMN. Plasma concentrationsof Although the sensitivity of the assay was adequate for measurement of total metanephrines, the concentrations of free metanephrines were close to the detection limits of the assay (0.12 pmol). The two-to fourfold greater sensitivity of the present method over that described by Pagliari et al. (11) has enabled accurate and reliable measurements of free NMN and MN in 1-mL samples of plasma. Plasma (Table 3) . A notable exception to this was interference from acetaminophen, which, although not efficiently extracted, was present in plasma after oral ingestion at concentrations sufficient to be detected by the assay (Figure 4) The method may also be useful for the diagnosis of pheochromocytoma.
